The spread of a new coronavirus (SARS-CoV-2) from Wuhan, China, has been fast, and the World Health Organization (WHO) declared a pandemic on March 11th, 2020 .It has now spread worldwide and is one of the most severe public health threats.The clinical characteristics of COVID-19 and the likelihood of transmission vertically or during delivery in pregnant women are still unknown.

In this cross sectional study,the following questions require immediate attention: whether COVID-19 symptoms in pregnant women differ from symptoms in non-pregnant women; whether disease complications and mortality rates are higher in pregnant women than in non-pregnant women; and whether there is a risk of premature delivery, foetal mortality, or even vertical transmission of the disease. These questions must be answered in order to plan optimal obstetrical management for pregnant women with COVID-19

Inclusion Criteria:

• Pregnant women of any gestational age with confirmed COVID 19 diagnosis attended and admitted at inpatient ward for management and follow up from April 2020 to December 2021at Kasr El Ainy hospital,Cairo university

Exclusion Criteria:

• there is no exclusion criteria

A retrospective analysis of prospectively collected data of pregnant women confirmed as COVID-19 infected.

Maternal and fetal morbidities and adverse obstetrical outcomes among those with COVID-19 will be analyzed.

Maternal outcomes will include:Venous thromboembolic events,pregnancy outcome,mode of delivery,frequency of admission to ICU,need for assistive ventilation,mortality rate Fetal outcomes will include:Frequency of NICU admission,Preterm birth,Intrauterine growth restriction,Intrauterine fetal death,Congenital fetal malformations.